← Back to Search

Light

Daytime Lighting for Sleep Regulation

N/A
Waitlist Available
Research Sponsored by Palo Alto Veterans Institute for Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18-65
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 hours
Awards & highlights

Study Summary

This trial looks at how different intensities of daytime light affects evening light sensitivity.

Who is the study for?
This trial is for healthy men and women aged 18-65 with normal color vision. It's not suitable for those who have extreme sleep patterns (chronotypes), significant hearing loss, depression, drug or alcohol use disorders, sleep disorders, or are regular smokers.Check my eligibility
What is being tested?
The study is exploring how different levels of light during the day affect our body's response to light in the evening. This could help understand how daytime light influences sleep quality and other non-visual responses to light.See study design
What are the potential side effects?
Since this trial involves exposure to varying intensities of light without any drugs or invasive procedures, side effects are minimal but may include eye strain or headache due to bright lighting conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Phase shift in the timing of melatonin onset
Suppression of melatonin production

Trial Design

4Treatment groups
Experimental Treatment
Group I: Normal roomExperimental Treatment1 Intervention
Normal intensity (150 lux) room light
Group II: Low roomExperimental Treatment1 Intervention
Low intensity (80 lux) room light
Group III: Bright roomExperimental Treatment1 Intervention
High intensity (500 lux) room light
Group IV: BrightExperimental Treatment1 Intervention
Very high intensity (1000 lux) room light
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Light
2016
Completed Phase 4
~90

Find a Location

Who is running the clinical trial?

Palo Alto Veterans Institute for ResearchLead Sponsor
52 Previous Clinical Trials
7,857 Total Patients Enrolled

Media Library

Daytime Lighting (Light) Clinical Trial Eligibility Overview. Trial Name: NCT04882280 — N/A
Sleep Research Study Groups: Low room, Normal room, Bright room, Bright
Sleep Clinical Trial 2023: Daytime Lighting Highlights & Side Effects. Trial Name: NCT04882280 — N/A
Daytime Lighting (Light) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04882280 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the trial open to seniors aged 65 and above?

"This medical trial is recruiting individuals between the ages of majority and seniority."

Answered by AI

Is this experiment currently open to participants?

"This particular medical trial is not actively recruiting, as indicated by clinicaltrials.gov. It was initially posted on July 1st 2022 and last updated on March 2nd 2022. In the meantime, however, there are 143 other trials that are presently enrolling patients for study participation."

Answered by AI

Am I eligible to be a subject in this research endeavor?

"This clinical trial is recruiting 48 suitable individuals, aged 18 to 65 and with a diagnosed sleep disorder. Candidates must also verify they are in good health, have no impairment of colour vision, and identify as either male or female."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
VA Palo Alto Health Care System
What portion of applicants met pre-screening criteria?
Met criteria
~2 spots leftby Jun 2024